WallStreetZenWallStreetZen

NYSE: NUVB
Nuvation Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nuvation Bio earnings were -$149.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest NUVB earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$62.8M, down 1,264.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NUVB reported annual earnings of -$204.6M, with -64% growth.

NUVB earnings history

Current Revenue
$169.9M
Current Earnings
-$149.8M
Current Profit Margin
-88.2%

NUVB Return on Equity

Current Company
-49.7%
Current Industry
-13.7%
Current Market
29%
NUVB's Return on Equity (-49.7%)... subscribe to Premium to read more.
High Return on Equity Performance

NUVB Return on Assets

Current Company
-23.5%
Current Industry
-10.4%
NUVB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NUVB announces earnings.

NUVB Return on Capital Employed

Current Company
-18.72%
Current Industry
-6.8%
NUVB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NUVB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NUVB-$121.19M-$149.83MN/A-$0.43
OCUL-$284.59M-$301.45MN/A-$1.40
BCRX-$304.20M-$384.67MN/A-$1.44
KOD-$216.41M-$241.99MN/A-$4.19
NKTR-$125.41M-$157.13MN/A-$6.51
View Top Biotech Stocks

Nuvation Bio Earnings Reports & History FAQ

What were Nuvation Bio's earnings last quarter?

On NUVB's earnings call on Aug 6, 2026, Nuvation Bio (NYSE: NUVB) reported Q2 2026 earnings per share (EPS) of -$0.18, up 5.88% year over year. Total NUVB earnings for the quarter were -$62.84 million. In the same quarter last year, Nuvation Bio's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Nuvation Bio stock.

Is Nuvation Bio profitable or losing money?

As of the last Nuvation Bio earnings report, Nuvation Bio is currently losing money. Nuvation Bio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$149.83 million, a 26.16% decrease year over year.

What was NUVB's earnings growth in the past year?

As of Nuvation Bio's earnings date in Aug 6, 2026, Nuvation Bio's earnings has grown year over year. NUVB earnings in the past year totalled -$149.83 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.